Cervical Dysplasia: The Daily PANCE Blueprint
A 35-year-old woman is seen for follow-up after a recent Pap smear showed high-grade squamous intraepithelial lesion (HSIL). She underwent colposcopy and biopsy, which confirmed cervical intraepithelial neoplasia grade 3 (CIN 3). A cervical conization procedure was performed, and the pathology report indicated CIN 3 with clear surgical margins. The patient is currently asymptomatic and has no history of cervical cancer or other significant gynecological issues. What is the most appropriate next step in management for this patient?
A. Endometrial biopsy
B. HPV-based testing at 6 months
C. Total hysterectomy
D. Annual Pap testing
E. Pap testing alone in 3 years
Answer and topic summary
The answer is B. HPV-based testing at 6 months
Patients with CIN 3 who have undergone a conization procedure with clear surgical margins are still at risk for recurrent dysplasia due to the potential persistence of human papillomavirus (HPV) infection. The appropriate management involves close surveillance with HPV-based testing at 6 months post-procedure. This strategy ensures early detection of any recurrence. If the HPV test is negative, annual HPV-based testing is recommended for the next three years.
Incorrect Answers:
- A. Endometrial biopsy: This procedure is indicated when there are concerns for endometrial pathology, such as abnormal uterine bleeding or atypical glandular cells on cytology. It is not necessary for a patient with CIN 3 who has undergone successful conization.
- C. Total hysterectomy: Hysterectomy may be considered for patients with persistent dysplasia or those who no longer desire fertility and have additional risk factors for recurrence. However, it is not the first-line management for patients with clear surgical margins after conization.
- D. Annual Pap testing: While Pap testing is part of cervical cancer screening, HPV testing is more sensitive for detecting recurrence in patients with a history of CIN 3. HPV-based testing is preferred over Pap testing alone in this high-risk population.
- E. Pap testing alone in 3 years: Delaying surveillance for three years after a high-grade lesion is inappropriate and increases the risk of missing recurrent disease. More frequent monitoring with HPV-based testing is necessary to ensure early detection of recurrence.
View blueprint lesson
Smarty PANCE Content Blueprint Review:
Covered under ⇒ PANCE Blueprint Reproductive System ⇒ ⇒
Also covered as part of the Women's Health Rotation topic list
